Wellington Management Group
DRUG

Wellington Management Group’s Bright Minds Biosciences DRUG Stock Holding History

Wellington Management Group’s Portfolio DRUG Stock Details DRUG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12M Buy
171,315
+34,638
+25% +$2.72M ﹤0.01% 1242
2026
Q1 		$9.97M Buy
136,677
+122,989
+899% +$9.9M ﹤0.01% 1239
2025
Q4 		$1.07M Buy
+13,688
New +$915K ﹤0.01% 1706

Other funds holding DRUG

JT
Jupiter Topco New York $245B AUM
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Wellington Management Group's DRUG Position: Q2 2026 in Review

Wellington Management Group increased its Bright Minds Biosciences (DRUG) stake by 25% in Q2 2026, buying an estimated $2.72M and bringing the position to 171,315 shares worth $12M. The position accounts for ﹤0.01% of the portfolio, ranked #1242.

Wellington Management Group first reported a position in DRUG in Q4 2025 and has held it in 3 quarters since. 100 funds tracked by Wall St. Rank hold DRUG as of Q2 2026.

  • Wellington Management Group held 171,315 shares of Bright Minds Biosciences worth $12M as of Q2 2026.
  • Wellington Management Group bought 34,638 Bright Minds Biosciences shares in Q2 2026, an estimated $2.72M.
  • Bright Minds Biosciences made up ﹤0.01% of Wellington Management Group's portfolio in Q2 2026, its #1242 holding.
  • Wellington Management Group first reported a position in Bright Minds Biosciences in Q4 2025 and has held it in 3 quarters since.
  • 100 funds tracked by Wall St. Rank held Bright Minds Biosciences as of Q2 2026.

Based on Wellington Management Group's 13F filing for Q2 2026, filed 14 Aug 2026.